TORNTPHARM

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM

BSE: 500420

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

4,896.50-108.5 (-2.17%)

21 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

91.9 / 100

Value Score

18.5 / 100

Price Momentum Score

84.9 / 100

QVM Score

79.8 / 100

Key Metrics

Market Cap

1,86,247 Cr

P/E (TTM)

85.38

P/B

22.14

P/S (TTM)

11.85

EV/EBITDA

38.32

CAPE (5Y)

104.53

ROE (TTM)

27.04

ROCE (TTM)

15.84

ROA (TTM)

7.30

Avg 3Y ROE

26.29

Earnings 3Y CAGR

18.59

Sales 3Y CAGR

16.81

Sales 5Y CAGR

14.23

Debt/Equity

1.79

Consensus TP

5399.00

Strong Buy %

30.00

Promoter Holding

68.31

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Torrent Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 84.9 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

84.9 / 100

High and stable ROE

The company reported strong ROE of 27.04% for 12-month ended 30 Jun 2026 and ROE improved marginally by 57 bps from 1 year ago

What is ROE (FY)?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 32.85% for 12-month ended 30 Jun 2026 and the growth was 22.26 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 32.85

-99.6111701.8

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 85.38 indicates that the stock is expensive on a standalone basis and is at a 178.11% premium to industry median P/E

What is P/E Ratio?

Median: 30.7

Value 85.38

-0.84752.64

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -13.38% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low EPS growth and in line with median growth of industry

The company delivered low EPS growth of 5.83% for 12-month ended 30 Jun 2026 and the growth was 1.37 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Reasonable Debt to Equity, but increasing

The company has reasonable Debt to Equity of 1.79 as on 30 Jun 2026 but Debt to Equity increased by 1.37 in the last 1 year

What is Debt to Equity?

Low dividend yield

The company has a low dividend yield of 0.78%

What is Dividend yield?

Neutral

High operating margin but declining trend

The company reported strong operating margin of 23.4% for 12-month ended 30 Jun 2026 but operating margin declined by -236 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of moderate quality

Earnings quality score of 45.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

45.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Torrent Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Torrent Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Torrent Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	68.31	68.31	68.31	68.31	68.31	68.31	68.31
Indian Promoter	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	71.25	68.31	68.31	68.31	68.31	68.31	68.31	68.31
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	20.68	20.70	20.61	20.05	19.72	20.07	20.25	20.57	20.62	20.81	20.87	20.96	21.04	21.16	21.16	21.30	21.40	21.49	21.54	24.52	24.66	24.74	25.20	25.27	25.24	25.27
Mutual Funds / UTI	8.15	7.62	7.23	6.90	6.47	6.66	6.71	6.73	7.48	7.78	6.72	6.23	6.37	5.59	5.32	4.48	4.46	4.35	3.69	4.88	5.03	4.95	5.12	4.83	4.45	4.94
FI/Bank/Insurance	0.03	0.02	0.04	0.04	0.06	0.05	0.05	0.04	0.04	0.04	2.16	1.99	1.87	1.99	1.85	1.96	1.95	2.01	1.89	1.70	1.31	1.62	1.89	1.72	1.97	2.22
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	9.82	10.99	12.17	11.96	11.37	11.65	11.53	11.63	10.88	10.80	11.37	12.09	12.04	12.85	13.15	14.08	14.14	14.22	14.46	16.17	16.31	16.09	15.92	16.13	16.18	15.44
Other Institutions	2.68	3.78	1.17	1.14	1.81	1.71	1.96	4.26	2.21	2.18	0.62	0.65	0.75	0.74	0.84	0.77	0.84	0.91	1.50	1.77	2.01	2.07	2.26	2.60	2.64	2.67
Non-Institution	8.08	8.05	8.14	8.70	9.03	8.68	8.51	8.18	8.14	7.95	7.88	7.80	7.71	7.60	7.60	7.45	7.36	7.26	7.21	7.17	7.03	6.94	6.49	6.42	6.45	6.42
Bodies Corporate	1.28	0.50	0.59	0.62	0.69	0.50	0.48	0.45	0.47	0.46	0.35	0.36	0.33	0.31	0.42	0.40	0.38	0.39	0.40	0.43	0.39	0.36	0.32	0.30	0.33	0.29
Others (incl. Retail) No. of shareholders	6.80 35,712	7.55 56,405	7.55 64,398	8.08 65,521	8.34 71,289	8.18 63,207	8.03 62,972	7.73 65,920	7.67 61,947	7.49 61,576	7.53 66,400	7.44 63,764	7.38 62,347	7.29 60,027	7.18 68,017	7.05 67,332	6.98 69,373	6.87 72,993	6.81 78,034	6.74 83,146	6.64 84,188	6.58 80,058	6.17 76,645	6.12 74,670	6.12 82,192	6.13 84,250

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Pharma	7.61%	4 / 20
2	Nifty Healthcare	6.54%	6 / 20
3	Nifty Alpha Low Vol 30	4.64%	1 / 30
4	Nifty 100 Low Volatility 30	3.28%	19 / 30
5	Nifty Next 50	2.97%	7 / 50
6	Nifty 200 Momentum 30	2.93%	19 / 30
7	Nifty 500 Momentum 50	2.84%	14 / 50
8	Nifty 100 Equal Weight	1.11%	10 / 100
9	Nifty 100	0.55%	52 / 100
10	Nifty 500	0.37%	54 / 499

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Torrent Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Average price	Qty.	Transaction value
Geena Malhotra Designated Person	June-2026	Market Purchase (Acquisition) 1st Jun 2026	₹ 4,002.99	200.00	₹ 8.01 lac
Geena Malhotra Designated Person	June-2026	Market Purchase (Acquisition) 1st Jun 2026	₹ 3,943.84	100.00	₹ 3.94 lac
Jinesh Shah Designated Person in capacity of trustee of Jinesh Trust Trust	November-2024	Off Market (Acquisition) 29th Nov 2024	₹ 0.00	9.30 lac	₹ 0.00
Shailesh Haribhakti Director	June-2021	Market Purchase (Acquisition) 25th Jun 2021	₹ 2,899.91	6.88 k	₹ 1.99 cr
Shailesh Haribhakti Director	June-2021	Market Purchase (Acquisition) 3rd Jun 2021	₹ 2,803.84	1.05 k	₹ 29.44 lac
Shailesh Haribhakti Director	June-2021	Market Purchase (Acquisition) 2nd Jun 2021	₹ 2,750.01	1.82 k	₹ 50.05 lac
Shailesh Haribhakti Director	June-2021	Market Purchase (Acquisition) 1st Jun 2021	₹ 2,736.97	730.00	₹ 19.98 lac
Harish Guttikar Connected Person	January-2021	Market Purchase (Acquisition) 6th Jan 2021	₹ 2,716.00	400.00	₹ 10.86 lac
Harish Guttikar Connected Person	January-2021	Market Sale (Disposal) 6th Jan 2021	₹ 2,778.00	200.00	₹ 5.56 lac

Corporate Actions

History of Torrent Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 9/share
Record date: 29th May 2026Ex-date: 29th May 2026
Announced on: 22nd May 2026
Dividend₹ 29/share
Record date: 19th Feb 2026Ex-date: 18th Feb 2026
Announced on: 3rd Feb 2026
Dividend₹ 6/share
Record date: 20th Jun 2025Ex-date: 20th Jun 2025
Announced on: 20th May 2025
Dividend₹ 26/share
Record date: 1st Feb 2025Ex-date: 31st Jan 2025
Announced on: 13th Jan 2025
Dividend₹ 6/share
Record date: 21st Jun 2024Ex-date: 21st Jun 2024
Announced on: 24th May 2024

Company Profile

Overview of Torrent Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company focuses on various therapeutic segments, s...

Key personnel

Shri. Sudhir Menon

Chief Financial Officer, Executive Director - Finance

Mr. Chintan M. Trivedi

Chief Compliance Officer, Company Secretary

Shri. Samir MehtaD

Executive Chairman of the Board

Shri. Sudhir MehtaD

Chairman Emeritus

Mr. Aman Samir MehtaD

Managing Director, Whole-Time Director

Mr. Manish ChoksiD

Lead Independent Director

Mr. Jinal MehtaD

Non-Executive Non-Independent Director

Ms. Nayantara BaliD

Independent Director

View all

Incorporated on

15 Jul 1972

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

17,729

IPO date

03 Nov 1994

Free Float

13,91,21,372

Website

https://www.torrentpharma.com/

Phone no.

+917926599000

Address

Avirat, Thaltej Shilaj Road, AHMEDABAD, 380059, India

Frequently Asked Questions

What is the current share price of Torrent Pharmaceuticals Ltd.?

The current share price of Torrent Pharmaceuticals Ltd. is ₹ 4,896.50 as of 21 Aug 2026.

What is the market capitalisation of Torrent Pharmaceuticals Ltd.?

The market capitalisation of Torrent Pharmaceuticals Ltd. stands at ₹ 1,86,247.00 Cr.

What is the PE ratio of Torrent Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Torrent Pharmaceuticals Ltd. is 85.38 as of the latest trailing twelve months data.

What is the ROE and ROCE of Torrent Pharmaceuticals Ltd.?

Torrent Pharmaceuticals Ltd. has a Return on Equity (ROE) of 27.04% and a Return on Capital Employed (ROCE) of 15.84% as per the latest financial reports.

What is the 52-week high and low of Torrent Pharmaceuticals Ltd.?

The 52-week high of Torrent Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Torrent Pharmaceuticals Ltd.?

The dividend yield of Torrent Pharmaceuticals Ltd. is 0.78% based on the current market price.

What is the FII and DII holding in Torrent Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 15.44%, Domestic Institutional Investors (DII) hold 7.16% and retail/public investors hold 6.13% of Torrent Pharmaceuticals Ltd. shares.

What sector does Torrent Pharmaceuticals Ltd. belong to?

Torrent Pharmaceuticals Ltd. operates in the Healthcare sector. 70% of analysts have a Buy or Strong Buy rating on Torrent Pharmaceuticals Ltd. with a consensus target price of ₹ 5,399.00, implying 10.26% upside from current levels.

What is the beta of Torrent Pharmaceuticals Ltd.?

The beta of Torrent Pharmaceuticals Ltd. is 0.23, indicating its price volatility relative to the broader market. Over the past 1 year, Torrent Pharmaceuticals Ltd. has delivered an absolute return of 35.34%.

What is the RSI of Torrent Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Torrent Pharmaceuticals Ltd. is 48.63, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Torrent Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Torrent Pharmaceuticals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Holdings and Presence

Company Profile